CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2016	Mar. 31, 2016
ASSETS
Cash and cash equivalents	$ 3,988,565	$ 9,270,010
Accounts receivable, net of allowance for doubtful accounts of $762,000 and $601,000 at December 31, 2016 and March 31, 2016, respectively	5,985,903	3,392,941
Other receivables	313,507	581,213
Due from affiliates	18,314	20,505
Prepaid expenses and other current assets	499,150	293,828
Total current assets	10,805,439	13,558,497
Deferred financing costs	0	37,926
Property and equipment, net	1,301,914	1,247,973
Restricted cash	765,000	530,000
Intangible assets, net	2,067,737	2,353,212
Goodwill	1,622,483	1,622,483
Other assets	221,987	216,442
TOTAL ASSETS	16,784,560	19,566,533
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY
Accounts payable and accrued liabilities	7,819,384	4,572,307
Medical liabilities	1,781,208	2,670,709
Note payable, net of debt discount of $5,733	394,267	0
Lines of credit	234,264	188,764
Total current liabilities	10,229,123	7,431,780
Warrant liability	0	2,811,111
Deferred rent liability	814,348	728,877
Deferred tax liability	43,479	43,479
Total liabilities	11,086,950	11,015,247
COMMITMENTS AND CONTINGENCIES AND SUBSEQUENT EVENTS
STOCKHOLDERS' EQUITY
Common Stock, par value $0.001; 100,000,000 shares authorized, 6,033,518 and 5,876,852 shares issued and outstanding as of December 31, 2016 and March 31, 2016, respectively	6,033	5,876
Additional paid-in-capital	25,908,699	23,524,517
Accumulated deficit	(33,090,937)	(28,684,565)
Stockholders' equity (deficit) attributable to Apollo Medical Holdings, Inc.	3,786,318	(1,269,427)
Non-controlling interest	1,911,292	2,742,935
Total stockholders' equity	5,697,610	1,473,508
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY	16,784,560	19,566,533
Series A Preferred Stock [Member]
STOCKHOLDERS' EQUITY
Series A Preferred stock, par value $0.001; 5,000,000 shares authorized (inclusive of Series B); 1,111,111 issued and outstanding Liquidation preference of $9,999,999 Series B Preferred stock, par value $0.001; 5,000,000 shares authorized (inclusive of Series A); 555,555 issued and outstanding Liquidation preference of $4,999,995	7,077,778	0
Series B Preferred Stock [Member]
STOCKHOLDERS' EQUITY
Series A Preferred stock, par value $0.001; 5,000,000 shares authorized (inclusive of Series B); 1,111,111 issued and outstanding Liquidation preference of $9,999,999 Series B Preferred stock, par value $0.001; 5,000,000 shares authorized (inclusive of Series A); 555,555 issued and outstanding Liquidation preference of $4,999,995	3,884,745	3,884,745
MEZZANINE | Series A Preferred Stock [Member]
MEZZANINE EQUITY [Abstract]
Series A Preferred stock, par value $0.001; 5,000,000 shares authorized (inclusive of Series B); 1,111,111 issued and outstanding	$ 0	$ 7,077,778